Table 1.
Characteristics of respondents and SCFA profiles.
| Characteristics | Mean/N | % |
|---|---|---|
| Age (year) | 59.15 ± 10.29 | |
| Sex | ||
| Men | 30 | 56.6 |
| Women | 23 | 43.4 |
| Sore Feet | ||
| Right | 21 | 39.6 |
| Left | 32 | 60.4 |
| LDL (mg/dL) * | 108 (35–183) | |
| HDL (mg/dL) * | 39 (5–83) | |
| Triglycerides (mg/dL) * | 130 (60–361) | |
| RBG (mg/dL) | 228.77 ± 73.11 | |
| Ankle Pressure (mmHg) * | 90 (0–140) | |
| Toe Pressure (mmHg) * | 60 (30–130) | |
| Brachial Pressure (mmHg) * | 120 (100–160) | |
| ABI * | 0.75 (0–1.17) | |
| PAD Degree | ||
| Rutherford 0–3 | 22 | 41.5 |
| Rutherford 4–6 | 31 | 58.5 |
| Short-Chain Fatty Acids | ||
| Acetate (%) | 57.45 ± 19.69 | |
| Absolute Acetate (mg/mL) * | 3.08 (0.28–19.35) | |
| Propionate (%) | 16.83 ± 10.04 | |
| Absolute Propionate (mg/mL) * | 1.25 (0.04–12.16) | |
| Butyrate (%) | 14.28 ± 10.13 | |
| Absolute Butyrate (mg/mL) * | 1 (0.01–13.6) | |
| Valerate (%) * | 2 (0.01–9.6) | |
| Absolute Valerate (mg/mL) * | 0.23 (0.01–5.03) | |
| Total SCFA (mg/mL) * | 7 (1–50) | |
LDL, low-density lipoprotein; HDL, high-density lipoprotein; RPG, random plasma glucose; ABI, ankle-brachial index; PAD, peripheral arterial disease; SCFA, short-chain fatty acids. Data are displayed in mean ± SD. * Data are displayed in median (Min; Max).